A regimen of intravenous iron therapy in iron-deficient patients with HF may improve HF-related symptoms and quality of life as well as exercise tolerance. However, it remains unknown whether intravenous iron supplements confer benefit when it comes to other outcomes, such as HF hospitalizations, cardiovascular-related mortality, and all-cause mortality.
In addition, achieving diabetes therapy targets may also confer beneficial effects on HF-related symptoms and health-related quality of life. Intensive treatment to achieve low A1c targets lessens the long-term risk for microvascular events, such as retinopathy, nephropathy, and peripheral neuropathy. Intensive glycemic control may also minimize the risk for nonfatal myocardial infarction.
Learn more about HF guidelines.
Medscape © 2021 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Ioana Dumitru. Fast Five Quiz: Heart Failure Comorbidities - Medscape - Jul 15, 2021.